Jusheng An

2.1k total citations · 1 hit paper
42 papers, 1.2k citations indexed

About

Jusheng An is a scholar working on Obstetrics and Gynecology, Oncology and Epidemiology. According to data from OpenAlex, Jusheng An has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Obstetrics and Gynecology, 16 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Jusheng An's work include Endometrial and Cervical Cancer Treatments (27 papers), Cervical Cancer and HPV Research (11 papers) and Colorectal and Anal Carcinomas (7 papers). Jusheng An is often cited by papers focused on Endometrial and Cervical Cancer Treatments (27 papers), Cervical Cancer and HPV Research (11 papers) and Colorectal and Anal Carcinomas (7 papers). Jusheng An collaborates with scholars based in China, United States and United Kingdom. Jusheng An's co-authors include K. L. Rinehart, Elise M. Jochimsen, Renato José Reis Molica, Sandra M. F. O. Azevedo, Susie Lau, Geoff K. Eaglesham, Wayne W. Carmichael, Lingying Wu, Ning Li and Hong‐Tu Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Environmental Health Perspectives.

In The Last Decade

Jusheng An

39 papers receiving 1.1k citations

Hit Papers

Human fatalities from cyanobacteria: chemical and biologi... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jusheng An China 12 712 408 247 217 178 42 1.2k
Dániel Beyer Germany 17 243 0.3× 68 0.2× 183 0.7× 74 0.3× 97 0.5× 57 769
Masami Nakanishi Japan 22 452 0.6× 425 1.0× 18 0.1× 539 2.5× 122 0.7× 99 1.3k
Jian Guo China 17 310 0.4× 176 0.4× 91 0.4× 140 0.6× 9 0.1× 50 883
Jaakko Lehtimäki Finland 16 376 0.5× 346 0.8× 112 0.5× 195 0.9× 4 0.0× 20 1.1k
Xiaohua Zhou China 15 105 0.1× 80 0.2× 46 0.2× 54 0.2× 89 0.5× 36 697
Xiannan Meng China 15 136 0.2× 50 0.1× 53 0.2× 30 0.1× 37 0.2× 25 954
Daniel Feurstein Germany 9 391 0.5× 188 0.5× 168 0.7× 80 0.4× 4 0.0× 15 615
Shideh Pouria United Kingdom 9 538 0.8× 299 0.7× 211 0.9× 145 0.7× 3 0.0× 11 1.1k
Jennifer Hill United States 14 42 0.1× 37 0.1× 64 0.3× 491 2.3× 127 0.7× 30 1.1k
Eva Caceres Sweden 13 203 0.3× 23 0.1× 20 0.1× 583 2.7× 78 0.4× 27 1.6k

Countries citing papers authored by Jusheng An

Since Specialization
Citations

This map shows the geographic impact of Jusheng An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jusheng An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jusheng An more than expected).

Fields of papers citing papers by Jusheng An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jusheng An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jusheng An. The network helps show where Jusheng An may publish in the future.

Co-authorship network of co-authors of Jusheng An

This figure shows the co-authorship network connecting the top 25 collaborators of Jusheng An. A scholar is included among the top collaborators of Jusheng An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jusheng An. Jusheng An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
An, Jusheng, Guiling Li, Jennifer Zhang, et al.. (2025). Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907). Gynecologic Oncology. 202. 33–40. 1 indexed citations
4.
Zhang, Lu, et al.. (2024). Cervical metastasis of breast cancer: A case report and literature review. Medicine. 103(32). e39275–e39275.
5.
Xie, Xin, et al.. (2023). Applying Multi-Metric Deformable Image Registration for Dose Accumulation in Combined Cervical Cancer Radiotherapy. Journal of Personalized Medicine. 13(2). 323–323. 2 indexed citations
6.
An, Jusheng, Xiu-Min Li, Jing Wang, et al.. (2023). Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1–positive advanced cervical cancer: a phase II, single-arm study. Frontiers in Immunology. 14. 1142256–1142256. 10 indexed citations
7.
Zhang, Xiaomiao, Jingwei Zhao, Qi Zhang, et al.. (2022). MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy. Cancer Imaging. 22(1). 35–35. 16 indexed citations
8.
Li, Jian, et al.. (2022). Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression. Annals of Translational Medicine. 10(2). 125–125. 4 indexed citations
9.
Zhang, Xiaomiao, Qi Zhang, Yan Chen, et al.. (2022). MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer. Abdominal Radiology. 48(1). 367–376. 6 indexed citations
10.
Zhang, Xiaomiao, Qi Zhang, Lizhi Xie, et al.. (2022). The Value of Whole-Tumor Texture Analysis of ADC in Predicting the Early Recurrence of Locally Advanced Cervical Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy. Frontiers in Oncology. 12. 852308–852308. 6 indexed citations
11.
Li, Wei, Jing Zuo, Yingjie Xu, et al.. (2022). A feasibility study of a modified treatment strategy combined external beam radiation therapy and brachytherapy for cervical cancer. Journal of Applied Clinical Medical Physics. 23(7). e13621–e13621. 1 indexed citations
12.
Li, Ning, et al.. (2021). Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys. Gynecologic Oncology Reports. 36. 100724–100724. 2 indexed citations
13.
Yu, Jing, Leilei Liang, Jing Liu, et al.. (2021). Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer. Frontiers in Genetics. 12. 733715–733715. 11 indexed citations
17.
Wu, Lingying, et al.. (2014). A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix. Radiation Oncology. 9(1). 55–55. 8 indexed citations
18.
An, Jusheng, Bin Li, Lingying Wu, Haizhen Lu, & Ning Li. (2009). Primary malignant amelanotic melanoma of the female genital tract: report of two cases and review of literature. Melanoma Research. 19(4). 267–270. 25 indexed citations
19.
Li, Ning, et al.. (2007). Treatment options in stage I endometrial stromal sarcoma: A retrospective analysis of 53 cases. Gynecologic Oncology. 108(2). 306–311. 66 indexed citations
20.
Carmichael, Wayne W., Sandra M. F. O. Azevedo, Jusheng An, et al.. (2001). Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins.. Environmental Health Perspectives. 109(7). 663–668. 808 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026